F20
Conditions
Interventions
Group 1: experimental group: the patients received a 3-hour manual-based inpatient medication training programme in four steps to arrange the medication
Group 2: control group: the patients received
Sponsors
ZfP Südwürttemberg und Universitätsklinik für Psychiatrie und Psychotherapie I Ulm
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: - main diagnosis: schizophrenic or schizo-affective-disorder (all WHO ICD-10 F20 and F25 diagnosis) - availability for katamneses (home visit): patients included in the study should live in the catchment areas of the Clinic Weissenau (district Ravensburg and Bodenseekreis), Clinic Ziwefalten and Reutlingen (district Reutlingen, Biberach, Alb-Donau) - no participation in an medication training program before
Exclusion criteria
Exclusion criteria: - after admission to hospital the length of stay is proposed to last shorter than two weeks - informed consent was not given - it is foreseeable, that the patient won't be self-responsible for the medication intake (e.g. assisted living) - medication only with depot neuroleptics - discharge before the training lasts at least 12 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| medcation adherence, measured by pill count, serum levels, self-rating Two follow-ups by study nurses were conducted, including taking blood samples for the measurement of the serum level of the antipsychotic medication. The first visit (t1) took place near to discharge from the hospital, the second (t2) four weeks after discharge. The patients were visited at home after a telephone call the day before. Blood samples were taken, pills were counted and the patients were asked to self-assess their medication intake. | — |
Secondary
| Measure | Time frame |
|---|---|
| Achievement of training-level, validated before discharge from the hospital | — |
Countries
Germany
Outcome results
None listed